Integrative therapy for leukemia
Acute myeloid leukemia (AML) remains a lethal hematologic malignancy because of frequent relapse, chemotherapy resistance, and treatment-related organ injury. Intensive chemotherapy can induce remission, but patients often succumb to relapsed disease. At the same time, chemotherapy-associated cardiotoxicity limits trea...